Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Simoneau

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Current Oncology (Toronto, Ont.)|November 3, 2016
Combined sorafenib and yttrium-90 radioembolization for the treatment of advanced hepatocellular carcinomaA Salman, E Simoneau, M Hassanain, et al.
The British Journal of Surgery|June 26, 2015
Portal vein embolization and its effect on tumour progression for colorectal cancer liver metastasesE Simoneau, M Hassanain, M Shaheen, et al.
Current Oncology (Toronto, Ont.)|October 25, 2013
Magnitude of change in alpha-fetoprotein in response to transarterial chemoembolization predicts survival in patients undergoing liver transplantation for hepatocellular carcinomaM Bhat, M Hassanain, E Simoneau, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Current Oncology (Toronto, Ont.)|November 3, 2016
Combined sorafenib and yttrium-90 radioembolization for the treatment of advanced hepatocellular carcinomaA Salman, E Simoneau, M Hassanain, et al.
The British Journal of Surgery|June 26, 2015
Portal vein embolization and its effect on tumour progression for colorectal cancer liver metastasesE Simoneau, M Hassanain, M Shaheen, et al.
Current Oncology (Toronto, Ont.)|October 25, 2013
Magnitude of change in alpha-fetoprotein in response to transarterial chemoembolization predicts survival in patients undergoing liver transplantation for hepatocellular carcinomaM Bhat, M Hassanain, E Simoneau, et al.
Pageof 2